-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Nabriva Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2015 to 2022.
- Nabriva Therapeutics plc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$5.62M, a 64.6% increase year-over-year.
- Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$36.7M, a 38.4% increase from 2021.
- Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$59.6M, a 16.5% increase from 2020.
- Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$71.3M, a 0.78% increase from 2019.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)